...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Vascular and endovascular surgery >Morbidity and mortality associated with renal insufficiency and endovascular repair of abdominal aortic aneurysms: a 5-year experience.
【24h】

Morbidity and mortality associated with renal insufficiency and endovascular repair of abdominal aortic aneurysms: a 5-year experience.

机译：与肾功能不全和腹主动脉瘤的血管内修复相关的发病率和死亡率：5年经验。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

To evaluate the outcome of patients with renal insufficiency undergoing endovascular repair of abdominal aortic aneurysm (AAA), data were prospectively collected between 1998 and 2003 on patients undergoing elective repair of their AAA with a stent graft. The patients were divided into 2 groups: those with serum creatinine (Crs) concentrations <1.2 (Group A) and those with Crs > or =1.2 mg/dL not requiring hemodialysis (Group B). The outcomes of the procedure for these 2 groups were compared. Different variables that existed between the 2 groups and contributed to mortality included estimated blood loss (EBL), volume of contrast used in the operating room, incidence of diabetes (DM), tobacco use, and history of myocardial infarction (MI). In total, 213 patients underwent elective repair of their AAA with use of a stent graft: 61% who had a Crs <1.2 mg/dL (Group A) and 39% who had a Crs > or =1.2 mg/dL not requiring dialysis (Group B). Among 129 patients with normal renal function there was an 18.6% complication rate and 1.6% mortality rate. Of 83 patients with renal insufficiency not on hemodialysis 30.1% (Fisher's Exact Test = 0.076) had 1 or more complications and there was a 6% (Fisher's Exact Test = 0.166) mortality rate. One patient in Group A (0.8%) progressed to hemodialysis and 5 (6%) patients in Group B progressed to end-stage renal disease requiring hemodialysis (p=0.068). A statistically significant higher proportion of the patients in Group B had a history of MI (p<0.001). There was no difference in the amount of EBL between the 2 groups, but a significantly lower amount of contrast (p<0.05) was used in patients with renal insufficiency.
机译：为了评估接受腹主动脉瘤（AAA）血管内修复的肾功能不全患者的结局，前瞻性收集了1998年至2003年之间通过支架植入物进行AAA择期修复的患者的数据。患者分为两组：血清肌酐（Crs）浓度<1.2（A组）和Crs>或= 1.2 mg / dL且无需血液透析的患者（B组）。比较了这两组的手术结果。两组之间存在并影响死亡率的不同变量包括估计失血量（EBL），手术室使用的造影剂量，糖尿病的发生率（DM），烟草使用和心肌梗塞病史（MI）。共有213例患者接受了支架移植术的AAA择期修复：61％的Crs <1.2 mg / dL（A组）和39％的Crs>或= 1.2 mg / dL无需透析（B组）。在129名肾功能正常的患者中，并发症发生率为18.6％，死亡率为1.6％。在没有进行血液透析的肾功能不全的83例患者中，有30.1％（Fisher's Exact Test = 0.076）有1个或更多并发症，死亡率为6％（Fisher's Exact Test = 0.166）。 A组中的1名患者（0.8％）进行了血液透析，B组中的5名（6％）患者进行了需要血液透析的终末期肾脏疾病（p = 0.068）。 B组中统计学上显着较高的患者有MI史（p <0.001）。两组之间的EBL量无差异，但肾功能不全的患者使用的造影剂量显着降低（p <0.05）。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号